Michael Gelband’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Sell
68,325
-173,061
-72% -$1.93M ﹤0.01% 1158
2026
Q1
$2.87M Buy
+241,386
New +$2.47M 0.02% 633
2025
Q4
Sell
-210,061
Closed -$1.88M 1492
2025
Q3
$1.88M Buy
+210,061
New +$1.95M 0.02% 751
2025
Q2
Sell
-56,629
Closed -$614K 1424
2025
Q1
$614K Buy
+56,629
New +$570K 0.01% 1067
2024
Q2
Sell
-58,721
Closed -$676K 1479
2024
Q1
$676K Buy
+58,721
New +$499K 0.01% 1068
2023
Q4
Sell
-75,019
Closed -$683K 1415
2023
Q3
$683K Buy
+75,019
New +$899K 0.01% 1120
2022
Q3
Sell
-184,452
Closed -$3.33M 1843
2022
Q2
$3.33M Sell
184,452
-182,832
-50% -$2.97M 0.04% 566
2022
Q1
$5.89M Sell
367,284
-104,210
-22% -$1.87M 0.07% 330
2021
Q4
$11.5M Buy
471,494
+361,300
+328% +$8.48M 0.12% 179
2021
Q3
$2.57M Buy
+110,194
New +$2.66M 0.03% 629
2021
Q1
Sell
-23,139
Closed -$869K 2080
2020
Q4
$869K Buy
+23,139
New +$716K 0.01% 935
2020
Q2
Sell
-27,851
Closed -$446K 1737
2020
Q1
$446K Sell
27,851
-27,091
-49% -$383K 0.02% 526
2019
Q4
$603K Buy
+54,942
New +$546K 0.01% 765

Other funds holding AHCO

Michael Gelband's AHCO Position: Q2 2026 in Review

Michael Gelband reduced its AdaptHealth (AHCO) stake by 72% in Q2 2026, selling an estimated $1.93M and leaving 68,325 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Michael Gelband first reported a position in AHCO in Q4 2019 and has held it in 13 quarters since. The position peaked at $11.5M in Q4 2021. 236 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Michael Gelband held 68,325 shares of AdaptHealth worth $712K as of Q2 2026.
  • Michael Gelband sold 173,061 AdaptHealth shares in Q2 2026, an estimated $1.93M.
  • AdaptHealth made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1158 holding.
  • Michael Gelband first reported a position in AdaptHealth in Q4 2019 and has held it in 13 quarters since.
  • Michael Gelband's AdaptHealth position peaked at $11.5M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.